Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure.
Krum
H
H
Monash University, Alfred Hospital, Prahran, Victoria, Australia.
Karrasch
J
J
Hamer
A
A
Hare
D
D
Howes
L G
LG
Jackson
B
B
Leslie
P
P
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D018592:Cross-Over Studies; D004334:Drug Administration Schedule; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007546:Isoquinolines / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D008297:Male; D000077583:Quinapril; D044005:Tetrahydroisoquinolines
D000806:Angiotensin-Converting Enzyme Inhibitors; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; D000077583:Quinapril